MedPath

Abrin

Brand Name: Abrin

Generic Name: Ivabradine (as hydrochloride)

Active
Registration Number

DR-XY49087

Dosage Form

Film-Coated Tablet

Issuance Date

May 21, 2024

Expiry Date

May 21, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength7.5 mg
PackagingAlu/Alu Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Other Cardiac Preparation.
A
Application
Initial (Reapplication)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ivabradine (as hydrochloride)Active
Monograph: ivabradine (as hydrochloride)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform